CANCER GENOMICS SERVICES

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into cancer genomics is revolutionizing precision oncology by enabling scalable, accurate, and clinically actionable analysis of complex genomic data. ArrayGen offers AI‑empowered cancer genomics services that turn raw sequencing data into actionable clinical insights. With automated pipelines for germline & somatic variant detection, rich annotation from leading databases, and expert‐guided interpretation in line with ACMG/AMP standards, we enable precise clinical reporting from assays like WGS, WES, and targeted panels. By integrating transcriptomic and epigenomic data, plus AI/ML‑based prioritization, our cancer genomics platform supports earlier detection, optimal therapy choice, and improved outcomes — especially for underrepresented populations. Quality, reproducibility, and data security form the backbone of all our services.



MVD_analysis

What We Do

  • Mutation Detection and Variant Calling
  • Clinical Sequencing Interpretation
  • Early Detection of Cancer from Whole Exome/Genome NGS Sequencing Data
  • Biomarker Discovery
  • Drug Target Validation
  • Driver Mutation Prediction
  • Tumor Classification and Subtyping
  • Tumor Microenvironment and Immunogenomics
  • Gene Expression & RNA-Seq Analysis
  • Prognostic and Survival Modeling
  • Gene Expression & RNA-Seq Analysis
  • Single-Cell Genomics and Spatial Analysis
  • Data Integration and Multi-Omics Fusion
  • TCGA Image Analysis
  • Pathological Image Analysis

Explore our tools and database


TGCA Expression Map
ArrayGen Heatmap Generator
Biomarker